Pemphigus Terminated Phase 3 Trials for Ofatumumab (DB06650)

IndicationStatusPhase
DBCOND0001806 (Pemphigus)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01920477Efficacy and Safety of Ofatumumab in Treatment of Pemphigus VulgarisTreatment
NCT02613910Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus VulgarisTreatment